M Hroch

1.3k total citations
70 papers, 1.0k citations indexed

About

M Hroch is a scholar working on Oncology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, M Hroch has authored 70 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 12 papers in Pharmacology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in M Hroch's work include Drug Transport and Resistance Mechanisms (24 papers), Liver Disease Diagnosis and Treatment (9 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). M Hroch is often cited by papers focused on Drug Transport and Resistance Mechanisms (24 papers), Liver Disease Diagnosis and Treatment (9 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). M Hroch collaborates with scholars based in Czechia, United States and Spain. M Hroch's co-authors include Jaroslav Chládek, Stanislav Mičuda, Jolana Cermanová, Michaela Adamcová, Martin Štěrba, Tomáš Šimůnek, Vladimír Geršl, Y Mazurová, Olga Popelová and Eva Doleželová and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

M Hroch

69 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Hroch Czechia 20 259 198 188 133 129 70 1.0k
Stanislav Mičuda Czechia 24 472 1.8× 405 2.0× 153 0.8× 92 0.7× 161 1.2× 97 1.5k
Ammar C. Al‐Rikabi Saudi Arabia 20 246 0.9× 291 1.5× 203 1.1× 320 2.4× 101 0.8× 69 1.4k
Jaroslav Chládek Czechia 22 155 0.6× 188 0.9× 49 0.3× 91 0.7× 87 0.7× 66 1.2k
Li‐Yu Tsai Taiwan 22 221 0.9× 574 2.9× 98 0.5× 145 1.1× 194 1.5× 67 1.7k
Marta Prieto Spain 20 201 0.8× 409 2.1× 93 0.5× 224 1.7× 61 0.5× 43 1.4k
A. Bernareggi United States 22 432 1.7× 399 2.0× 92 0.5× 138 1.0× 95 0.7× 63 1.3k
Nir I. Weijl Netherlands 16 418 1.6× 291 1.5× 137 0.7× 320 2.4× 45 0.3× 22 1.4k
J.A. Gevers Leuven Netherlands 27 139 0.5× 523 2.6× 345 1.8× 134 1.0× 159 1.2× 69 2.4k
Mohamed S. Abdel‐Bakky Egypt 20 247 1.0× 670 3.4× 57 0.3× 140 1.1× 112 0.9× 67 1.5k
Michele Visentin Switzerland 19 412 1.6× 581 2.9× 44 0.2× 116 0.9× 243 1.9× 55 1.8k

Countries citing papers authored by M Hroch

Since Specialization
Citations

This map shows the geographic impact of M Hroch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Hroch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Hroch more than expected).

Fields of papers citing papers by M Hroch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Hroch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Hroch. The network helps show where M Hroch may publish in the future.

Co-authorship network of co-authors of M Hroch

This figure shows the co-authorship network connecting the top 25 collaborators of M Hroch. A scholar is included among the top collaborators of M Hroch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Hroch. M Hroch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lestavel, Sophie, Véronique Touche, Eva Kudová, et al.. (2025). The farnesoid X receptor (FXR) antagonist 7β-isopropylchenodeoxycholic acid improves glucose metabolism in mice on a Western diet. Pharmacological Research. 221. 107950–107950. 2 indexed citations
2.
Hroch, M, et al.. (2024). Futures of algorithms and choices. Central European Journal of Communication. 17(1(35)). 38–60. 2 indexed citations
3.
Hroch, M, et al.. (2024). Roundtable discussion: Perspectives on the Futures of Platforms and Democracy. Central European Journal of Communication. 17(1(35)). 125–140.
4.
Hroch, M, et al.. (2024). Direct Multi‐Deuterium Labelling of Pirtobrutinib. Journal of Labelled Compounds and Radiopharmaceuticals. 67(9). 314–323. 1 indexed citations
5.
Carpentier, Nico, et al.. (2023). Bridging the Discursive and Material Dimensions of Europeanity and Europeanisation. Observatorio (OBS*). 17(1). 3 indexed citations
6.
Nová, Zuzana, M Hroch, Jaroslav Mokrý, et al.. (2023). Carvedilol impairs bile acid homeostasis in mice: implication for nonalcoholic steatohepatitis. Toxicological Sciences. 196(2). 200–217. 4 indexed citations
7.
Hroch, M, Radim Havelek, Martina Řezáčová, et al.. (2022). Semisynthetic derivatives of haemanthamine and their in vitro antiproliferative activity evaluation against a panel of human cell lines. Arabian Journal of Chemistry. 15(5). 103746–103746. 6 indexed citations
8.
Cermanová, Jolana, M Hroch, Zuzana Nová, et al.. (2022). Multidrug Resistance-Associated Protein 2 Deficiency Aggravates Estrogen-Induced Impairment of Bile Acid Metabolomics in Rats. Frontiers in Physiology. 13. 859294–859294. 4 indexed citations
9.
Hroch, M, Radomı́r Hyšpler, Alena Tichá, et al.. (2020). Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver. International Journal of Molecular Sciences. 21(23). 9021–9021. 10 indexed citations
10.
Holas, Ondřej, M Hroch, Tomáš Smutný, et al.. (2020). 3β-Isoobeticholic acid efficiently activates the farnesoid X receptor (FXR) due to its epimerization to 3α-epimer by hepatic metabolism. The Journal of Steroid Biochemistry and Molecular Biology. 202. 105702–105702. 7 indexed citations
11.
Rejchrt, Stanislav, et al.. (2019). Investigation of 23 Bile Acids in Liver Bile in Benign and Malignant Biliary Stenosis: A Pilot Study. Gastroenterology Research and Practice. 2019. 1–7. 7 indexed citations
12.
Cermanová, Jolana, M Hroch, Pavel Tomšík, et al.. (2015). Boldine enhances bile production in rats via osmotic and Farnesoid X receptor dependent mechanisms. Toxicology and Applied Pharmacology. 285(1). 12–22. 20 indexed citations
13.
14.
Neckář, Jan, Gudrun H. Borchert, Olga Nováková, et al.. (2013). Brief Daily Episode of Normoxia Inhibits Cardioprotection Conferred by Chronic Continuous Hypoxia. Role of Oxidative Stress and BK<sub>Ca</sub> Channels. Current Pharmaceutical Design. 19(39). 6880–6889. 19 indexed citations
15.
16.
Hirsova, Petra, Eva Doleželová, Jolana Cermanová, et al.. (2012). Cholestatic effect of epigallocatechin gallate in rats is mediated via decreased expression of Mrp2. Toxicology. 303. 9–15. 26 indexed citations
17.
18.
Popelová, Olga, Martin Štěrba, Pavlína Hašková, et al.. (2009). Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death. British Journal of Cancer. 101(5). 792–802. 52 indexed citations
19.
Fuksa, Leoš, Eva Brčáková, Jolana Cermanová, et al.. (2008). Amiodarone modulates pharmacokinetics of low‐dose methotrexate in rats. Biopharmaceutics & Drug Disposition. 29(5). 289–299. 8 indexed citations
20.
Hroch, M, et al.. (1966). [Enterpathogenic Escherichia coli in infants. The immunofluorescent method].. PubMed. 21(12). 1085–90. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanislav Mičuda Breakdown of academic impact, for papers by Ammar C. Al‐Rikabi Breakdown of academic impact, for papers by Jaroslav Chládek Breakdown of academic impact, for papers by Li‐Yu Tsai Breakdown of academic impact, for papers by Marta Prieto Breakdown of academic impact, for papers by A. Bernareggi Breakdown of academic impact, for papers by Nir I. Weijl Breakdown of academic impact, for papers by J.A. Gevers Leuven Breakdown of academic impact, for papers by Mohamed S. Abdel‐Bakky Breakdown of academic impact, for papers by Michele Visentin
Rankless by CCL
2026